MedTrace Logo

Korean Coronary Bifurcation Stenting (COBIS) Registry II

NCT01642992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2873

Last updated 2013-01-10

No results posted yet for this study

Summary

The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in Korea, a total of 2,873 patients were enrolled in this database between January 2003 and December 2009.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with drug-eluting stents for coronary bifurcation lesions in South Korea.

Conditions

  • Coronary Bifurcation Lesion

Sponsors & Collaborators

  • Hyeon-Cheol Gwon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01642992 on ClinicalTrials.gov